Results 211 to 220 of about 770,723 (305)

Bilateral adrenal metastasis of renal cell carcinoma 4 years after radical nephrectomy: A case report and review of literature. [PDF]

Medicine (Baltimore), 2021
Li Y, Ji Z, Wang D, Xie Y.
europepmc   +1 more source

Case of metachronous bilateral isolated adrenal metastasis from colorectal adenocarcinoma and review of the literature.

World Journal of Gastroenterology, 2016
Yu-yi Liu, Zhi-hui Chen, E. Zhai, Jie Yang, Jian-bo Xu, S. Cai, W. Song   +6 more
semanticscholar   +1 more source

Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 606-611, February 2026.
Mitotane is an adrenolytic drug with cytotoxic effects, registered for the treatment of advanced adrenocortical carcinoma (ACC), a rare but aggressive tumour type with a poor prognosis despite treatment. Recently, the oral multi‐kinase inhibitor cabozantinib has shown promising results as a potential second‐line treatment option.
Annemieke M. Peters van Ton, Nielka P. van Erp, Annenienke C. van de Ven, Janneke E. W. Walraven, Loek A. W. de Jong   +4 more
wiley   +1 more source

Synchronous multifocal osteosarcoma with atypical adrenal metastasis: a case report and literature review. [PDF]

Ann Med Surg (Lond)
Awwad HH, Assi AK, Khaled ZA, Owienah H, Abulilhya M, Azzam KS, Bashir B, Sweileh T, Eleyan F.   +8 more
europepmc   +1 more source

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava, Sudhakar Venkatesh, Michael S. Torbenson, Patrick S. Kamath, Moira Hilscher   +4 more
wiley   +1 more source

A Rare Presentation of Hepatocellular Carcinoma: Adrenal Metastasis Mimicking Primary Adrenal Malignancy. [PDF]

Cureus
Muchard RD, Park EG, Woodward C, Johnson CD.   +3 more
europepmc   +1 more source

Prognostic significance of the postoperative/preoperative serum CEA level ratio in patients with solitary adrenal metastasis from lung cancer. [PDF]

Mol Clin Oncol, 2022
Yajima S, Nakanishi Y, Matsumoto S, Tanabe K, Tsuboi M, Masuda H.   +5 more
europepmc   +1 more source

Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Aim Integration of locoregional treatments (LRTs) with atezolizumab plus bevacizumab (atezo/bev) has improved treatment outcomes, enabling an increasing number of patients with unresectable hepatocellular carcinoma (HCC) to achieve a complete response (CR). A comprehensive analysis of recurrence following CR may provide insights into prognosis.
Tasuku Nakabori, Masaki Kawabata, Kaori Mukai, Hidenari Hongyo, Noboru Maeda, Makiko Urabe, Yugo Kai, Ryoji Takada, Kenji Ikezawa, Hiroshi Wada, Kunihito Gotoh, Kazuyoshi Ohkawa   +11 more
wiley   +1 more source

Prediction of solitary ≤3-cm small adrenal metastasis based on ¹⁸F-FDG PET/CT using a support vector machine model in lung cancer. [PDF]

Oncol Lett
Zhao L, Cai H, Li J, Zhao W, Liu Y, Cao L.   +5 more
europepmc   +1 more source

Incidental Solitary Adrenal Metastasis as the Initial Manifestation of a Solid Variant of Papillary Thyroid Carcinoma, With Emphasis on Pathologic Diagnosis and Clinical Management. [PDF]

AACE Clin Case Rep, 2022
Karalis JD, Jia L, Murvelashvili N, Vora A, Tessnow A, Dackiw APB.   +5 more
europepmc   +1 more source